Stockscreener 앱 받기
4.83
2.23%
-0.11
시간 외 거래:
4.81
-0.02
-0.41%
Optimizerx Corp 주식(OPRX)의 최신 뉴스
OptimizeRx Q1 earnings call highlights - MSN
OptimizeRx Corp. and DeepIntent Announce First Integration of EHR Network into Healthcare Advertising Platform - Quiver Quantitative
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network - The Manila Times
OptimizeRx Corp. Integrates Proprietary Electronic Health Record Network Into DeepIntent Healthcare Advertising Platform - marketscreener.com
OPRX Technical Analysis | Trend, Signals & Chart Patterns | OPTIMIZERX CORP (NASDAQ:OPRX) - ChartMill
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds - qz.com
OptimizeRx Corp. Sees Valuation Upgrade Amid Positive Financial Trends and High Institutional Confidence - Markets Mojo
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold? - sharewise.com
OptimizeRx Corp stock (US6837631027): earnings momentum and buyback plan put focus back on digital h - AD HOC NEWS
OptimizeRx (OPRX) CCO logs Form 4 tax-withholding share dispositions - Stock Titan
OptimizeRx (OPRX) CEO has 5,219 shares withheld to cover RSU tax - Stock Titan
OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout
OptimizeRx Corp stock (US6837631027): earnings beat, buyback plan and volatile AI-health rally - AD HOC NEWS
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead? - Yahoo Finance
Some OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance
OptimizeRx Corp stock (US6837631027): Bank note points to valuation reset - AD HOC NEWS
OptimizeRx (OPRX) Q1 2026 Earnings Transcript - The Globe and Mail
OptimizeRx Secures New Credit Facility to Boost Flexibility - The Globe and Mail
OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com
OptimizeRx (NASDAQ: OPRX) cuts Q1 loss as margins improve and debt refinanced - Stock Titan
Stifel cuts OptimizeRx stock price target on weaker guidance - Investing.com UK
B. Riley Adjusts Price Target on OptimizeRx to $10 From $11, Maintains Buy Rating - marketscreener.com
Stifel cuts OptimizeRx stock price target on weaker guidance By Investing.com - Investing.com Australia
OptimizeRx Corporation (NASDAQ:OPRX) Q1 2026 Earnings Call Transcript - Insider Monkey
OPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - The Manila Times
Earnings call transcript: OptimizeRx Q1 2026 beats estimates, stock rises - Investing.com UK
OptimizeRx Exceeds Expectations with Strong Q1 Growth - Intellectia AI
OptimizeRx Q1 Earnings Call Highlights - sharewise.com
Earnings Call Summary | OptimizeRx(OPRX.US) Q1 2026 Earnings Conference - Moomoo
OptimizeRx Corp. (OPRX) surpasses Q1 earnings and revenue estimates - MSN
OptimizeRx Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: OptimizeRx Q1 2026 beats estimates, stock rises By Investing.com - Investing.com Nigeria
Optimizerx Corp enters credit agreement with Fifth Third Bank on May 7, 2026SEC filing - marketscreener.com
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
OPTIMIZERx earnings beat by $0.13, revenue topped estimates - Investing.com
OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance - ChartMill
OptimizeRx Corporation (OPRX) Releases Q1 2026 Earnings: Revenue Down but Beats; EPS Miss - Quiver Quantitative
OptimizeRx (Nasdaq: OPRX) posts Q1 2026 results and secures $35M credit facility - Stock Titan
Press Release: OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance - Moomoo
OptimizeRx Corporation Launches Programmatic Access to Authenticated EHR Advertising - marketscreener.com
Optimizerx launches programmatic access to authenticated EHR advertising at scale - marketscreener.com
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale - marketscreener.com
Pharma ads go programmatic inside doctors' EHRs via OptimizeRx - Stock Titan
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
OptimizeRx Corp expected to post breakeven results a shareEarnings Preview - TradingView
2.59%
3.97%
자본화:
|
볼륨(24시간):